Soleus Capital Management’s Taysha Gene Therapies TSHA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-925,000	Closed	-$2.65M	–	111
2024 Q1	$2.65M	Buy	+925,000	New	+$2.65M	0.2%	73